dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Cardiology Homepage

John D. Zehren Endologix appoints chief commercial officer

Medtronic to acquire EPIX Therapeutics Will use EPIX's cardiac ablation technology with Medtronic's cryoballoon technology

Centerline Biomedical submits IOPS system for FDA clearance Designed as alternative to X-ray fluoroscopy

Philips unveils Azurion angiography system with FlexArm positioning System moves on eight different axes with single controller

FDA clears RFPi's iCertainty blood flow and perfusion imaging solution No injections, dyes, radiation, direct patient contact or interruptions in procedures

FDA gives nod to new clearance for iSchemaView’s RAPID platform Can help select which stroke patients require clot removal procedures

Rob Beanlands ASNC names president for 2019

Hill-Rom Holdings launches LINQ Mobile App that connects care team members to one another, patients and patient info in real time

FDA gives green light for Edwards' SAPIEN 3 Ultra system Provides transcatheter aortic valve replacement to patients facing surgical risks

Boston Scientific to acquire shares of Millipede for $325 million Initially bought $90 million worth of shares a year ago

A new tool images the amount of
plaque built up in atherosclerosis
over time

New tool images amount of plaque present in atherosclerosis

by John R. Fischer , Staff Reporter
Imaging exact amounts of plaque built up in arteries may soon be viable with a new tool developed at the University of Tsukuba.

Using mice as test subjects, Japanese researchers have demonstrated the ability to visually measure the amount of atherosclerotic plaque developed over time and track its progression, enabling accurate evaluations of drugs for treating atherosclerosis and the potential analysis of likely risks posed by such plaque including reductions in blood flow.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510



"Because we can now clearly analyze the amount of plaque present and its change over time, our work should lead to more effective monitoring of how well anti-atherosclerotic drugs work," corresponding author Michito Hamada said in a statement. "This method can also reduce the number of experimental animals used because there's no need to sacrifice them and remove tissues for analysis at each time point within an experiment."

Though advances in medicine have provided better understanding of how plaque buildup occurs and ways to reduce it, diseases associated with atherosclerosis continue to be a major factor in the mortality rate.

The team induced atherosclerosis in mice by inactivating a fat and cholesterol-related receptor, placing each within one of three groups. Mice were also exposed to X-rays that destroyed the native cells of their immune system, with genetically engineered immune cells designed to exhibit fluorescence transplanted within them as replacements.

Each group was fed its own feeding pattern, with one receiving a high-cholesterol diet daily; another a diet that alternated between this and a normal one every other week; and a third that was strictly fed a normal one.

Using the intensity of the fluorescent signal exposed the stepwise variations in plaque quantity within each group, with clear increases in plaque amount shown in the one that consumed the unhealthy diet most frequently. The findings validate the tool's efficiency for not just confirming the presence of plaque but also the amount present.

"A main advantage of our approach is that the introduced immune cells, as macrophages, congregate in atherosclerotic plaque, so the level of fluorescence emitted by them strongly correlates with the amount of plaque that has formed," another author, Yoshihiro Miwa, said in a statement. "Because the expressed fluorescent proteins emit light in the near-infrared part of the spectrum, they can be detected at deeper locations within the body, such as the thoracic aorta."

The findings were published in the journal, Scientific Reports.

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED